NO20081253L - Klebepreparat inneholdende bisopropol - Google Patents

Klebepreparat inneholdende bisopropol

Info

Publication number
NO20081253L
NO20081253L NO20081253A NO20081253A NO20081253L NO 20081253 L NO20081253 L NO 20081253L NO 20081253 A NO20081253 A NO 20081253A NO 20081253 A NO20081253 A NO 20081253A NO 20081253 L NO20081253 L NO 20081253L
Authority
NO
Norway
Prior art keywords
bisoprolol
adhesive
adhesive composition
skin surface
skin
Prior art date
Application number
NO20081253A
Other languages
English (en)
Inventor
Yoshihiro Iwao
Katsuyuki Ookubo
Katsuhiro Okada
Kunihiro Minami
Schuichiro Yuasa
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Publication of NO20081253L publication Critical patent/NO20081253L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det tilveiebringes et adhesivt preparat som har en lav irritasjon overfor hudoverflaten, har fremragende stabilitet for bisoprolol i preparatet og videre er i stand til å kontinuerlig administrere en farmakologisk effektiv mengde av bisoprolol til den levende kroppen. Det adhesive prepratet har en bærer (1) og et klebrig sjikt (2) som er lagdelt på en overflate av bæreren (1). Det klebrige sjikt (2) er kjennetegnet ved å inneholde bisoprolol, polyisobutylen, en klebriggjører og en organisk flytende komponent som er kompatibel med polyisobutylen og klebriggjøreren. På denne måten kan det adhesive preparat som har god hudadhesjon, lav hudirritasjon og redusert smerte eller adhesjonsmiddelrest ved tidspunktet for fjerning fra hudoverflaten tilveiebringes. Videre tilveiebringes det adhesive preparat hvori stabiliteten av bisoprolol i det adhesive preparat er fremragende og den farmakologisk effektive mengde av bisoprolol kan administreres kontinuerlig til den levende kroppen gjennom hudoverflaten.
NO20081253A 2005-09-09 2008-03-10 Klebepreparat inneholdende bisopropol NO20081253L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005262559 2005-09-09
JP2006235270A JP5058531B2 (ja) 2005-09-09 2006-08-31 ビソプロロール含有貼付製剤
PCT/JP2006/317764 WO2007029781A1 (ja) 2005-09-09 2006-09-07 ビソプロロール含有貼付製剤

Publications (1)

Publication Number Publication Date
NO20081253L true NO20081253L (no) 2008-06-09

Family

ID=37835896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081253A NO20081253L (no) 2005-09-09 2008-03-10 Klebepreparat inneholdende bisopropol

Country Status (15)

Country Link
US (1) US8808731B2 (no)
EP (2) EP1932523B1 (no)
JP (1) JP5058531B2 (no)
KR (1) KR101246400B1 (no)
AR (1) AR055412A1 (no)
AU (1) AU2006288260B2 (no)
BR (1) BRPI0615762A2 (no)
CA (1) CA2621867C (no)
DK (1) DK1932523T3 (no)
IL (1) IL189991A (no)
NO (1) NO20081253L (no)
NZ (1) NZ566494A (no)
RU (1) RU2396951C2 (no)
TW (1) TWI426930B (no)
WO (1) WO2007029781A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5058531B2 (ja) 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP5015562B2 (ja) * 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
JP4945228B2 (ja) * 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
NZ579240A (en) * 2007-03-08 2011-03-31 Nitto Denko Corp Device for the transdermal administration of bisoprolol
WO2009026133A2 (en) * 2007-08-17 2009-02-26 Alza Corporation Transdermal bisoprolol delivery system
JP5615697B2 (ja) 2008-03-25 2014-10-29 帝國製薬株式会社 β遮断剤の安定化組成物およびそれを用いた経皮吸収製剤
EP2286814B1 (en) * 2008-05-15 2013-10-16 Hisamitsu Pharmaceutical Co., Inc. Transdermal preparation containing palonosetron
US20100092544A1 (en) * 2008-10-14 2010-04-15 Katsuhiro Okada Adhesive composition for patch and use thereof
KR20110127215A (ko) 2009-02-18 2011-11-24 히사미쓰 세이야꾸 가부시키가이샤 경피 흡수 제제
CN102413821A (zh) 2009-05-01 2012-04-11 久光制药株式会社 经皮吸收型制剂
JP5776079B2 (ja) * 2010-02-26 2015-09-09 日東電工株式会社 ビソプロロール含有貼付製剤
JP6318355B2 (ja) * 2013-09-06 2018-05-09 日東電工株式会社 ビソプロロール含有貼付製剤
JP2015051947A (ja) * 2013-09-06 2015-03-19 日東電工株式会社 ビソプロロール含有貼付製剤およびその包装体
JP6318356B2 (ja) * 2013-09-06 2018-05-09 日東電工株式会社 ビソプロロール含有貼付製剤およびその包装体
JP6528154B2 (ja) * 2013-09-06 2019-06-12 日東電工株式会社 ビソプロロール含有貼付製剤
WO2015133329A1 (ja) * 2014-03-06 2015-09-11 帝國製薬株式会社 貼付製剤
CN107922805B (zh) 2015-08-17 2020-09-15 3M创新有限公司 纳米粘土填充的阻挡粘合剂组合物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP2512565B2 (ja) * 1989-10-13 1996-07-03 積水化学工業株式会社 貼付剤
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5149719A (en) 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
JPH0813956B2 (ja) 1990-06-22 1996-02-14 積水化学工業株式会社 表面保護フィルムの製造方法
JP3355671B2 (ja) 1992-11-09 2002-12-09 旭化成株式会社 粘接着剤用組成物
JPH07330591A (ja) 1994-06-06 1995-12-19 Kanegafuchi Chem Ind Co Ltd 経皮吸収製剤
DE19512181C2 (de) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
WO1996040085A2 (en) 1995-06-07 1996-12-19 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JPH10152434A (ja) * 1996-09-26 1998-06-09 Nitto Denko Corp 経皮吸収型製剤
JP4119502B2 (ja) 1997-07-08 2008-07-16 埼玉第一製薬株式会社 新規な経皮吸収促進剤を含有する外用剤組成物
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
US20040142024A1 (en) 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
CA2394506C (en) * 1999-12-15 2006-06-27 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparations
FR2807323A1 (fr) 2000-04-10 2001-10-12 Oreal Composition, notamment cosmetique, renfermant un steroide et un 2-alkyl alcanol ou un ester
DE10033853A1 (de) 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
JP2002038114A (ja) 2000-07-26 2002-02-06 Aicello Chemical Co Ltd 粘着付与マスターバッチ及びこれを用いた粘着フィルム
JP4358978B2 (ja) 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤
JP2002187836A (ja) * 2000-12-21 2002-07-05 Oishi Koseido:Kk 貼付剤
JP4478757B2 (ja) * 2002-04-19 2010-06-09 日東電工株式会社 ビソプロロール含有貼付剤
JP2004244585A (ja) 2003-02-17 2004-09-02 Nippon Shokubai Co Ltd 粘着剤組成物および粘着製品
JP4694967B2 (ja) 2003-07-31 2011-06-08 久光製薬株式会社 貼付剤
US20070158227A1 (en) * 2004-01-30 2007-07-12 Satoshi Amano Plaster enclosing packaging bag
US7168810B2 (en) 2004-04-23 2007-01-30 Infocus Corporation Method and apparatus for arranging light emitting devices in projection systems
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
MX2007004315A (es) 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
EP1847264B1 (en) 2005-01-31 2017-05-03 Hisamitsu Pharmaceutical Co., Inc. Bisoprolol patch
JP4782438B2 (ja) 2005-02-17 2011-09-28 日東電工株式会社 貼付製剤
JP5058531B2 (ja) 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP5015562B2 (ja) 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
JP4945228B2 (ja) 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
NZ579240A (en) 2007-03-08 2011-03-31 Nitto Denko Corp Device for the transdermal administration of bisoprolol

Also Published As

Publication number Publication date
US8808731B2 (en) 2014-08-19
IL189991A0 (en) 2008-08-07
WO2007029781A1 (ja) 2007-03-15
TWI426930B (zh) 2014-02-21
TW200800144A (en) 2008-01-01
AU2006288260B2 (en) 2011-05-26
DK1932523T3 (da) 2011-11-14
BRPI0615762A2 (pt) 2011-05-24
EP2359823A1 (en) 2011-08-24
EP1932523B1 (en) 2011-07-27
RU2396951C2 (ru) 2010-08-20
JP2007099759A (ja) 2007-04-19
IL189991A (en) 2014-07-31
CA2621867A1 (en) 2007-03-15
EP1932523A4 (en) 2008-11-26
NZ566494A (en) 2010-10-29
AU2006288260A1 (en) 2007-03-15
KR101246400B1 (ko) 2013-03-21
EP1932523A1 (en) 2008-06-18
JP5058531B2 (ja) 2012-10-24
US20090291126A1 (en) 2009-11-26
RU2008113846A (ru) 2009-10-20
CA2621867C (en) 2012-12-18
AR055412A1 (es) 2007-08-22
KR20080041692A (ko) 2008-05-13

Similar Documents

Publication Publication Date Title
NO20081253L (no) Klebepreparat inneholdende bisopropol
WO2006055752A3 (en) INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME
WO2006002361A3 (en) 2-methylpropanamides and their use as pharmaceuticals
WO2007084314A3 (en) MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2008108958A8 (en) Benzimidazole derivatives and methods of use thereof
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
SG161261A1 (en) Lactam compounds and their use as pharmaceuticals
WO2008137758A3 (en) Amino acid lipids and uses thereof
WO2007038138A3 (en) Amido compounds and their use as pharmaceuticals
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ECSP067114A (es) Piperidinas n-sustituidas y su uso como farmacéuticos
CL2009000967A1 (es) Compuesto 4-ciclobutil-n-((2s,5r)-5-hidroxi-2-adamantil)-2-morfolin-4-ilpiridin-5-carboxamida, inhibidor de la enzima 11betahsd1; composicion farmaceutica que lo comprende; y su uso en un procedimiento de tratamiento profilactico o terapeutico de un animal de sangre caliente.
CL2007003614A1 (es) Compuestos derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona; composicion farmaceutica que comprende a dicho compuesto; procedimiento de preparacion; y uso del compuesto en el tratamiento de trastornos del metabolismo, como diabetes mellitus, dis
WO2007067504A3 (en) Lactam compounds and methods of using the same
WO2006012227A3 (en) Amido compounds and their use as pharmaceuticals
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
WO2005116002A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2008108957A3 (en) Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
NO20100301L (no) Forbedrete brimonidinsammensetninger for behandling av erytem
SG151329A1 (en) Amido compounds and their use as pharmaceuticals
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
WO2007062413A3 (en) Use of parp-1 inhibitors
NO20072542L (no) Pyrimidinderivat kondensert med ikke-aromatisk ring
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application